Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 16, 2021
December 17, 2021
3db61da7-cb07-4d7e-b933-ef2ea35c7c1c
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities
Guidance DocumentOctober 26, 2023Center for Drug Evaluation and Research
Postapproval Changes to Drug Substances Guidance for Industry
Guidance DocumentSeptember 11, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox